Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY:ENOV)

31.10 -0.89 (-2.78%)
Streaming Delayed Price Updated: 1:21 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enovis Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >
Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences
From Enovis Corporation
Via GlobeNewswire
1 Russell 2000 Stock Worth Your Attention and 2 We Avoid
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
1 Unprofitable Stock to Own for Decades and 2 Facing Challenges
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Why Enovis (ENOV) Stock Is Trading Up Today
Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the afternoon session after the company announced the sale of its Dr. Comfort diabetic shoe business to Promus Equity... 
Via StockStory
Topics Artificial Intelligence Economy Government
Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
Enovis (ENOV) Stock Trades Up, Here Is Why
Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 4.3% in the afternoon session after the company announced the sale of its Dr. Comfort diabetic shoe business to Promus Equity... 
Via StockStory
Topics World Trade
Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million
From Enovis Corporation
Via GlobeNewswire
3 Value Stocks with Open Questions
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics Economy Government World Trade
1 of Wall Street’s Favorite Stock to Consider Right Now and 2 Facing Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
3 Small-Cap Stocks with Questionable Fundamentals
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q2
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - specialty stocks, including Enovis (NYSE:ENOV) and its peers. 
Via StockStory
1 Russell 2000 Stock with Exciting Potential and 2 Facing Headwinds
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
3 Volatile Stocks We Approach with Caution
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Artificial Intelligence Economy
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know
A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Stocks
ENOV Q2 Deep Dive: New CEO Prioritizes Organic Growth, Margin Expansion, and Product Pipeline
Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.5% year on year to $564.5 million. The company’s full-year... 
Via StockStory
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Enovis’s (NYSE:ENOV) Q2 Sales Beat Estimates, Stock Jumps 10.3%
Medical technology company Enovis Corporation (NYSE:ENOV) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.5% year on year to $564.5 million. The company’s... 
Via StockStory
Topics Earnings
Enovis Corp (NYSE:ENOV) Reports Mixed Q2 2025 Results with EPS Beat and Revenue Miss
Enovis Corp (ENOV) reported mixed Q2 2025 results, with revenue slightly missing estimates but adjusted EPS beating forecasts. Shares rose 6.9% pre-market as the company raised full-year guidance. 
Via Chartmill
Enovis (ENOV) Q2 Revenue Rises 7%
Via The Motley Fool
Topics Earnings
Enovis Announces Second Quarter 2025 Results
From Enovis Corporation
Via GlobeNewswire
Enovis Earnings: What To Look For From ENOV
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday before market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
3 of Wall Street’s Favorite Stocks That Fall Short
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Enovis (ENOV) Stock Trades Up, Here Is Why
Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the morning session after the stock gained ground amid a broader market rally as investors looked ahead to a busy week... 
Via StockStory
Topics Lawsuit Stocks
Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
Enovis to Host Second Quarter 2025 Results Conference Call on August 7th
From Enovis Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.